EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of Bioinformatics Software for Drug Discovery and Design

Dr. David Thompson

American Journal of Bioinformatics · 31.08.2025 · 6 (4) · 1-6

DOI: 10.71465/ajb.3382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Bioinformatics, online erschienen am 31.08.2025. Verfasst von Dr. David Thompson. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioinformatics software has become an essential tool in drug discovery and design, enabling researchers to analyze and predict molecular interactions, optimize drug candidates, and reduce the time and cost of drug development. The integration of bioinformatics techniques such as molecular docking, virtual screening, and quantitative structure-activity relationship (QSAR) modeling has revolutionized the process of drug design. This article explores the development of bioinformatics software tools used in drug discovery, focusing on their applications in target identification, drug screening, and lead optimization. We also discuss the challenges faced in developing these tools and the future directions in bioinformatics-driven drug design.

Zitieren

APA

Thompson, D. D. (2025). Development of Bioinformatics Software for Drug Discovery and Design. American Journal of Bioinformatics, 6(4), 1-6. https://doi.org/10.71465/ajb.3382

Vancouver

Thompson DD. Development of Bioinformatics Software for Drug Discovery and Design. American Journal of Bioinformatics. 2025;6(4):1-6. doi:10.71465/ajb.3382

BibTeX
@article{Thompson2025,
  author = {Thompson, Dr. David},
  title = {Development of Bioinformatics Software for Drug Discovery and Design},
  journal = {American Journal of Bioinformatics},
  year = {2025},
  volume = {6},
  number = {4},
  pages = {1--6},
  doi = {10.71465/ajb.3382}
}
Kostenlos starten →